REGN Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

$684.70  +23.56 (3.56%)
As of 05/23/2022 14:13:06 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/01/2001
Outstanding shares:  108,028,048
Average volume:  631,957
Market cap:   $70,990,631,743
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2730190

---

Valuation   (See tab for details)

---

PE ratio:   9.00
PB ratio:   3.57
PS ratio:   4.30
Return on equity:   39.84%
Net income %:   48.06%